SCHEMBL6157345

SCHEMBL6157345

CC(=O)c1cccc(CCc2ccc(C(O)O)cc2)c1

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
MAOB P27338 7/20 0.43
LTB4R Q15722 2/20 0.42
KMT2A Q03164 5/20 0.42
CYP4F2 P78329 1/20 0.42
CYP4A11 Q02928 1/20 0.42
MEN1 O00255 3/20 0.41
TAAR1 Q96RJ0 1/20 0.41
LMNA P02545 2/20 0.41
MAOA P21397 2/20 0.40
MAPT P10636 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HTT P42858 1/20 0.40
EPHX1 P07099 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3283557 0.85 LTB4R (0.41) LTB4RCYP4F2CYP4A11MAPTALDH1A1
SCHEMBL9660695 0.83 MAOB (0.58) MAOBKMT2ACYP4F2CYP4A11MEN1
SCHEMBL6884477 0.80 KMT2A (0.55) KMT2AMEN1TAAR1LMNAMAPT
SCHEMBL6155402 0.80 MRGPRX4 (0.64) MAOBMAOA
SCHEMBL8341269 0.77 CYP4F2 (0.53) MAOBKMT2ACYP4F2CYP4A11MEN1
SCHEMBL4958280 0.76 KAT6A (0.51) MAOBCYP4F2CYP4A11LMNAMAOA
SCHEMBL12235066 0.76 CYP4F2 (0.67) MAOBCYP4F2CYP4A11LMNAMAOA
SCHEMBL6157330 0.76 VDR (0.50) MAOBCYP4F2CYP4A11LMNAMAOA
SCHEMBL10442102 0.76 ALDH1A1 (0.47) KMT2AMEN1LMNAMAPTALDH1A1
SCHEMBL6158543 0.76 PPARA (0.47) MAOBKMT2AMEN1MAOAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1124779-B1 VITAMIN D ANALOGUES GALDERMA RES & DEV (FR) 2005-02-02 EP disclosed
US-6689922-B1 BIAROMATIC COMPOUNDS WHICH ARE ANALOGUES OF VITAMIN D HAVE A MARKED ACTIVITY IN THE FIELDS OF CELL DIFFERENTIATION AND PROLIFERATION GALDERMA RESEARCH & DEVELOPMENT S.N.C. (FR) 2004-02-10 US disclosed